Pharma companies ‘€˜deny medicine to millions’€™ ‘€“ Oxfam
Big pharmaceutical companies need to change the way they work to reach 85% of the world'€™s consumers who don'€™t have proper access to medicine.
Health
Read More » Pharma companies ‘€˜deny medicine to millions’€™ ‘€“ Oxfam
Microbicide hope Living with AIDS # 331
Results from the first ever microbocide trial to go through all phases of research are due to be released early next year. A microbicide is a substance that can be inserted vaginally or anally with the aim of protecting its users from HIV infection.
‘TB a scandal’
It'€™s a scandal that tuberculosis has not been given proper attention and this is mainly because it is a disease of the poor, said Nils Billo, Executive Director of the International Union Against Tuberculosis (TB) and Lung Disease (The Union).
Diabetes on the rise
As the international community is focusing on HIV/AIDS, malaria and tuberculosis another rapidly growing epidemic, diabetes, is also demanding attention.
‘TB a scandal’
It'€™s a scandal that tuberculosis has not been given proper attention and this is mainly because it is a disease of the poor, said Nils Billo, Executive Director of the International Union Against Tuberculosis (TB) and Lung Disease (The Union).
AIDS in SA is stable or in decline – UNAIDS
HIV/AIDS in southern Africa appears to be stablising but there is no room for complacency, according to the UNAIDS annual HIV/AIDS statistics released today (20 November)
Conference renews interest in TB Living with AIDS # 330
Improved diagnostics, new medicines for drug resistant TB, the integration of HIV and TB treatment, increased funding and political will are some of the resources needed for a stronger effort against Tuberculosis.
AIDS denialist Brink calls Suresh Roberts a liar
Anthony Brink takes on Ronald Suresh Roberts over his portrayal of Mbeki'€™s views on HIV/AIDS
Call for new approach on drug-resistant TB
The French humanitarian agency, Doctors Without Borders (MSF), has called for a new approach in dealing with patients with Multi-Drug Resistant Tuberculosis.
Treat MDR TB in the communities
Decentralising the treatment of multi-drug resistant (MDR) tuberculosis (TB) to community level is gaining popularity as the way forward.
Thousands call for action on TB
Activists have called for global action to stem the tide of deaths attributed to tuberculosis.
Strong link between smoking and TB
Up to 20 percent of the global tuberculosis (TB) burden may be attributable to tobacco smoking, research has confirmed.
‘TB out of control in Zimbabwe’
Tuberculosis (TB) and its drug resistant strain is out of control in Zimbabwe, advocacy organisations in the country have warned.
Smoking children – cause for concern, warn experts
Health experts say the high level of tobacco use among South African children of school going age is worrisome.
Discovery of new MDR TB drugs critical Living with AIDS # 329
The world is in desperate need of better medicines to deal both with the increase in multi-drug resistant TB and the problem of the co-infection of TB and HIV, say experts.